The first drug to complete the cure of Cancer successfully in the first Tests?

Cancer-free after only a few weeks of treatment?

Cancer costs unfortunately, more and more people. Around the world, physicians are actively seeking ways to prevent cancer, to improve the existing therapies, or in the best case, a complete cure of the disease. Israeli scientists now claim that they have developed a cure for cancer, which could already be in a year, and the disease can heal in just a few weeks.

The experts of Accelerated Evolution Biotechnologies Ltd., declared now that they could offer in the future a cure for cancer, which can cure the disease within just a few weeks, according to the magazine „The Jerusalem Post“. The treatment should have minimal or no side effects and a much lower cost than most other available on the market treatments available.

Treatment requires only a few weeks

The new treatment to cure cancer is from the first day to be effective, only takes a couple of weeks and has minimal or no side effects. The desired solution will be available both generically as well as in person, explain the researchers, told the newspaper.

When will Multi-Target Toxin for people be available?

The scientists have may actually be evidence that your medicine could be finished in only a year, it is likely, however, that patients have to wait up to a decade before the treatment is actually available. Previously, it must be confirmed that the therapy is safe and effective. The drug bears the name of MuTaTo (Multi-Target-Toxin). It acts as an antibiotic against cancer, say the developers.

Why are many cancer treatments unsuccessful?

In their research work, the experts wanted to find out why other cancer drugs and treatments work, or at some point cease to be effective. Then they set about to find a solution for these problems. Most anti-cancer drugs to attack a specific target, or in the cancer cell, explain the researchers. You fail, because the target is mutated. Cancer cells start to divide and spread, so as to avoid a successful treatment. So the original drug, which has attacked this goal is, eventually, unusable, and the therapy no longer works.

Drug attacks three targets at the same time

MuTaTo will not be affected by mutations, because the treatment attacks three targets at the same time. Not even cancer can mutate three receptors at the same time, scientists say. The treatment could distinguish between healthy and not healthy, the sick cells. This will reduce the unpleasant side-effects, which in the majority of current treatments such as chemotherapy.

So far it has been successful in experiments with mice

So far, the claims of the researchers are based, however, only in experiments on mice. The next step of the proof in the laboratory that the treatment of human cancer models, to work, would be the experts to explain. If there is evidence that the drug is in such a laboratory test to be effective, should scientists run it through the clinical trials phases I, II and III, to determine whether it is really safe and effective in people. Unfortunately, it can take ten to 15 years or more, up to all three phases of the clinical trials are completed prior to licensing.

MuTaTo is highly allow for personalized treatment

Factors including the type of cancer, type of treatment and the duration of the treatment can all affect the duration of the medication. MuTaTo will allow one day cancer patients a highly personalized treatment, biopsies can be sent for test purposes, so that Doctors can determine the exact dose that each Patient to cure his disease needed, say the doctors.

Patients remain in the treatment of disease

The treatment may need to be in the best case, only a few weeks to heal. Patients remain after treatment, disease-free, say the researchers. But the experts had to admit that you are just starting with clinical studies, the completion of which can take years. Although the statements of the doctors are quite exciting, it seems to be still a long way to go before the prospect of a cure of cancer. (as)